in

Pakistan to Become The First Country to Complete Research on IVIG for Treating Coronavirus

Pakistan is all set to become the first country to successfully conclude research on the intravenous immunoglobulin (IVIG) treatment for the Coronavirus disease, scientists at Karachi’s Dow University of Health Sciences (DUHS) have claimed.

According to DOW researchers, 100% of the Coronavirus patients in serious condition had recovered after they were administered the IVIG treatment during its clinical trial.


ALSO READ

Private Schools to Reopen Next Month Without Govt’s Approval


The recovery rate among COVID-19 patients in critical condition who were admitted to ICU stood at 60% during the trials.

Moreover, the IVIG treatment significantly brought down the hospitalization period among both seriously and critically ill Coronavirus patients from 20-25 days to 5-7 days.

Dr. Shaukat Ali, Head of Biotechnology Department at DUHS, has said that Pakistan became the first country to develop IVIG treatment for COVID-19 in April this year.


ALSO READ

UK Reports Exponential Rise in Infections Due to a New Strain of Coronavirus


DUHS developed the IVIG treatment by chemically purifying the plasma extracted from the blood donated by Coronavirus patients after recovering from the disease.

Once administered, the IVIG treatment neutralizes the virus and stabilizes the immune system while the antibodies in IVIG stops the secondary bacterial infection, said Dr. Shaukat.

Source from :

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

    President Alvi Officially Enacts Anti-Rape Ordinance 2020

    Facebook Will Now Tell You About Fake COVID-19 Related Posts